ADMA Biologics
company
Funding Rounds
Number of Funding Rounds
Total Funding Amount
16
$607.35M 0
ADMA Biologics has raised a total of
$607.35M 0 in funding over 2 rounds. Their latest funding was raised on
Dec 7, 2022 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | Post-IPO Equity | $60M | — | — | — | Detail |
| Mar 24, 2022 | Post-IPO Debt | $150M | 1 | Hayfin Capital Management | — | Detail |
| Feb 6, 2020 | Post-IPO Equity | $82.30M | — | — | — | Detail |
| May 22, 2019 | Post-IPO Equity | $51.75M | — | — | — | Detail |
| Feb 12, 2019 | Post-IPO Debt | $72.50M | 1 | Perceptive Advisors | — | Detail |
| Jun 7, 2018 | Post-IPO Equity | $40M | — | — | — | Detail |
| Nov 9, 2017 | Post-IPO Equity | $42M | — | — | — | Detail |
| Oct 11, 2017 | Post-IPO Debt | $30M | 1 | Marathon Asset Management | — | Detail |
| May 13, 2016 | Post-IPO Debt | $4M | 1 | Oxford Finance LLC | — | Detail |
| Jun 22, 2015 | Post-IPO Debt | $21M | 1 | Oxford Finance LLC | — | Detail |
| Mar 12, 2015 | Post-IPO Equity | $10.30M | — | — | — | Detail |
| Dec 15, 2014 | Post-IPO Debt | $5M | 1 | — | — | Detail |
| Feb 27, 2014 | Post-IPO Debt | $15M | 1 | — | — | Detail |
| Oct 18, 2013 | IPO | — | — | — | — | Detail |
| Jan 7, 2013 | Debt Financing | $6M | 1 | Hercules Capital | — | Detail |
| Feb 13, 2012 | Series Unknown | $17.50M | 3 | Burrill & Company | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
